logo

For the Inventor, By the Inventor

Hazelwood, MO, United States of America

Ocera Therapeutics, Inc.


USPTO Granted Patents = 26



Forward Citations = 202

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal Keith Anderson (11 out of 15 patents)

silverMedal Peter Manini (10 out of 25 patents)

bronzeMedal Jim Behling (10 out of 10 patents)

4.  Christine Henderson Dougan (10 out of 10 patents)

5.  Stephen William Watt (10 out of 15 patents)

6.  Attilia Figini (10 out of 10 patents)

7.  Eric Marsault (8 out of 24 patents)

8.  Kamel Benakli (6 out of 11 patents)

9.  Mark L Peterson (5 out of 21 patents)

10.  Carl St-Louis (5 out of 8 patents)

11.  Hamid R Hoveyda (5 out of 51 patents)

12.  Graeme Lovat Fraser (4 out of 38 patents)

13.  Luc Ouellet (3 out of 13 patents)

14.  Sophie Beauchemin (3 out of 9 patents)

15.  Ruoxi Lan (2 out of 37 patents)


26 patents:

1. 11266620 - Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate (2022-03-08),
2. 11219611 - Formulations of L-ornithine phenylacetate (2022-01-11),
3. 11161802 - L-ornithine phenyl acetate and methods of making thereof (2021-11-02),
4. 11066352 - Processes of making L-ornithine phenylacetate (2021-07-20),
5. 10835506 - Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate (2020-11-17),
6. 10550069 - L-ornithine phenyl acetate and methods of making thereof (2020-02-04),
7. 10258602 - Macrocyclic ghrelin receptor modulators and methods of using the same (2019-04-16),
8. 10173964 - L-ornithine phenyl acetate and methods of making thereof (2019-01-08),
9. 10040751 - Intermediates for macrocyclic compounds (2018-08-07),
10. 9949949 - Macrocyclic ghrelin receptor modulators and methods of using the same (2018-04-24),
11. 9604909 - L-ornithine phenyl acetate and methods of making thereof (2017-03-28),
12. 9493505 - Macrocyclic modulators of the ghrelin receptor (2016-11-15),
13. 9409945 - Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery (2016-08-09),
14. 9371297 - Macrocyclic ghrelin receptor modulators and methods of using the same (2016-06-21),
15. 9260379 - Methods of making L-ornithine phenyl acetate (2016-02-16),
Ocera Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of transformative medicines for patients with unmet medical needs in the gastrointestinal and liver diseases. They aim to improve the lives of patients with innovative treatments that directly address the underlying causes of their conditions. With a strong pipeline and dedicated team, Ocera Therapeutics is committed to making a positive impact in the healthcare industry.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

26 Patents

#4 in Hazelwood, MO

#167 in Missouri

#12,451 in US

#24,092 in the World

...
Hazelwood, MO, United States of America

Ocera Therapeutics, Inc.

Forward Citations = 202

36 inventors:

goldMedal Keith Anderson (11 out of 15 patents)

silverMedal Peter Manini (10 out of 25 patents)

bronzeMedal Jim Behling (10 out of 10 patents)

4.  Christine Henderson Dougan (10 out of 10 patents)

5.  Stephen William Watt (10 out of 15 patents)

Please report any incorrect information to support@idiyas.com
Loading…